Distress Screening Program for Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a distress screening and referral program can assist cancer patients experiencing emotional stress. The program uses the NCCN Distress Thermometer to assess patient distress levels and connects them with mental health support if necessary. The study targets patients recently diagnosed with a new solid tumor and receiving treatment at Jamaica Hospital Medical Center. It welcomes English and Spanish speakers who believe they might benefit from additional mental health support. As an unphased trial, this study provides patients the opportunity to access potentially beneficial mental health support tailored to their needs.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial team or your doctor.
What prior data suggests that this distress screening program is safe for cancer patients?
Research has shown that the NCCN Distress Thermometer reliably measures distress in cancer patients. It uses a simple 0 to 10 scale to assess distress levels. Many studies have proven its effectiveness in real-life medical settings, and it is recommended for use when patients first receive a cancer diagnosis.
The tool is non-invasive, involving no physical procedures, and serves to understand a patient's emotional state. As a screening tool, it carries no side effects or risks, making it a safe option for identifying distress and ensuring patients receive necessary mental health support.12345Why are researchers excited about this trial?
Researchers are excited about the NCCN Distress Thermometer because it offers a novel way to address the emotional well-being of cancer patients, which is often overlooked. Unlike traditional cancer treatments that focus solely on the physical aspects of the disease, this tool helps identify and quantify the level of psychological distress a patient might be experiencing. By providing a quick and easy screening method for emotional distress, healthcare providers can offer timely support and interventions, potentially improving the overall quality of life for patients with a new solid tumor diagnosis.
What evidence suggests that the NCCN Distress Thermometer is effective for distress screening in cancer patients?
Research shows that the NCCN Distress Thermometer effectively measures the distress levels of cancer patients. It uses a simple 0 to 10 scale to assess a patient's distress. Studies have found it works well for many patients, making it a valuable tool in medical settings. Although it may not always be perfectly accurate, it helps identify patients who might need mental health support. This tool is particularly helpful because it quickly highlights patients who could benefit from additional mental health services.12678
Who Is on the Research Team?
Devika Jutagir, PhD
Principal Investigator
Memorial Sloan Kettering Cancer Center
Are You a Good Fit for This Trial?
This trial is for people who have been recently diagnosed with cancer. It aims to include a diverse group of participants, including both English and Spanish speakers.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Distress Screening and Referral
Participants are screened for psychosocial distress and referred to mental health services if distress levels are high
Follow-up
Participants are monitored for referral outcomes and mental health service engagement
What Are the Treatments Tested in This Trial?
Interventions
- NCCN Distress Thermometer
Find a Clinic Near You
Who Is Running the Clinical Trial?
Memorial Sloan Kettering Cancer Center
Lead Sponsor